Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:490-495

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Redon, J.
Right arrow Articles by Cooper, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Redon, J.
Right arrow Articles by Cooper, R. S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Genetics of cardiovascular disease
Right arrow Functional genomics

(Hypertension. 2000;35:490.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Influence of the I/D Polymorphism of the Angiotensin-Converting Enzyme Gene on the Outcome of Microalbuminuria in Essential Hypertension

Josep Redon; Felipe Javier Chaves; Youlian Liao; Jose Maria Pascual; Eduardo Rovira; Maria Eugenia Armengod; Richard S. Cooper

From the Instituto Investigaciones Citológicas (F.J.C., M.E.A.), Fundación Valenciana de Investigaciones Biomédicas; Hypertension Clinic (J.R.), Internal Medicine, Hospital Clínico, University of Valencia; Internal Medicine (J.M.P., E.R.), Hospital of Sagunto; and Department of Preventive Medicine and Epidemiology (Y.L., R.S.C.), Loyola University Medical School, Maywood, Ill.

Correspondence to Dr Josep Redon, Hypertension Clinic, Hospital Clínico, Avda Blasco Ibañez, 17, 46010 Valencia, Spain. E-mail josep.redon{at}uv.es

Abstract—The objective of the present study was to analyze the influence of the I/D polymorphism of the ACE gene on the outcome of microalbuminuria in essential hypertensive patients who were receiving antihypertensive treatment. One hundred thirty-six essential hypertensive patients who were <50 years old and had never previously received treatment with antihypertensive drugs were included in the study. During a 3-year period, patients received nonpharmacological treatment consisting of moderate salt restriction and a low-calorie diet they were obese, with or without a regimen of antihypertensive drugs based on ß-blockers or ACE inhibitors. Hydrochlorothiazide was added when necessary to maintain the blood pressure goal of <135/85 mm Hg. At the beginning of the study and at yearly intervals, systolic and diastolic blood pressures (SBP and DBP, respectively), 24-hour urinary albumin excretion (UAE), renal function, and biochemical profile measurements were made. The insertion/deletion (I/D) polymorphism of the ACE gene was determined through the use of polymerase chain reaction. The variables used in the statistical analysis were the measurements at the start of the study and the increase or decrease detected during the follow-up, estimated as individual specific regression line slope values. At baseline, no differences in blood pressure or UAE values were observed among genotypes. Likewise, the genotype or allele frequency was not significantly different between normoalbuminurics and microalbuminurics. After the 3 treatment years, significant reductions in SBP, DBP, and UAE were found (SBP 151.6±17.3 reduced to 137.2±14.3 mm Hg, P<0.001; DBP 96.6±8.9 reduced to 84.5±9.8 mm Hg, P<0.001; UAE 36.7±71.5 reduced to 28.3±78.6 mg/24 h, P<0.05). The slopes of these parameters over time did not differ significantly among genotypes. The slope of SBP was the main factor related to the slope of logUAE (P<0.003). A significant positive correlation coefficient between the SBP and logUAE slopes was observed for the DD patients (r=0.57, P<0.0001) but was absent in patients carrying the I allele (II r=-0.03, P=NS; I/D r=0.01, P=NS). Follow-up studies should be used to achieve a better understanding of the impact of candidate gene polymorphisms on the development of hypertension-induced organ damage. Assessment of the I/D polymorphism of the ACE gene may identify subjects who require a greatly lowered blood pressure to prevent organ damage and to reduce hypertension-associated complications and death.


Key Words: hypertension, essential • albuminuria • genetics • angiotensin-converting enzyme gene




This article has been cited by other articles:


Home page
HypertensionHome page
J. M. Pascual, E. Rodilla, C. Gonzalez, S. Perez-Hoyos, and J. Redon
Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension
Hypertension, June 1, 2005; 45(6): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. J. Chaves, D. Corella, J. V. Sorli, P. Marin-Garcia, M. Guillen, and J. Redon
Polymorphisms of the Renin-Angiotensin System Influence Height in Normotensive Women in a Spanish Population
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2301 - 2305.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Redon, E. Rovira, A. Miralles, R. Julve, and J. M. Pascual
Factors Related to the Occurrence of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension
Hypertension, March 1, 2002; 39(3): 794 - 798.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.T Real, F.J Chaves, I Martinez-Uso, A.B Garcia-Garcia, J.F Ascaso, and R Carmena
Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia
Eur. Heart J., March 2, 2001; 22(6): 465 - 471.
[Abstract] [PDF]